rociletinib | |
---|---|
Trade Name | |
Orphan Indication | Non-small cell lung cancer |
USA Market Approval | USA |
USA Designation Date | 2013-05-14 00:00:00 |
Sponsor | Clovis Oncology, Inc.;5500 Flatiron Parkway, Suite 100;Boulder, Colorado, 80301 |
Related Access Program